Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P02768: Variant p.Asp574Gly

Albumin
Gene: ALB
Feedback?
Variant information Variant position: help 574 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LB/B The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Aspartate (D) to Glycine (G) at position 574 (D574G, p.Asp574Gly). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and acidic (D) to glycine (G) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Polymorphism: help A variant structure of albumin could lead to increased binding of zinc resulting in an asymptomatic augmentation of zinc concentration in the blood. The sequence shown is that of variant albumin A. Additional information on the polymorphism described.
Variant description: help In Mexico. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 574 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 609 The length of the canonical sequence.
Location on the sequence: help VELVKHKPKATKEQLKAVMD D FAAFVEKCCKADDKETCFAE The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 25 – 609 Albumin
Domain 404 – 601 Albumin 3
Site 562 – 562 Not glycated
Site 565 – 565 Not glycated
Site 581 – 581 Not glycated
Site 584 – 584 Not glycated
Site 588 – 588 Not glycated
Modified residue 558 – 558 N6-methyllysine; alternate
Modified residue 588 – 588 N6-succinyllysine
Glycosylation 558 – 558 N-linked (Glc) (glycation) lysine; alternate
Glycosylation 560 – 560 N-linked (Glc) (glycation) lysine; in vitro
Glycosylation 569 – 569 N-linked (Glc) (glycation) lysine; in vitro
Disulfide bond 538 – 583
Helix 565 – 583



Literature citations
Amino acid substitutions in genetic variants of human serum albumin and in sequences inferred from molecular cloning.
Takahashi N.; Takahashi Y.; Blumberg B.S.; Putnam F.W.;
Proc. Natl. Acad. Sci. U.S.A. 84:4413-4417(1987)
Cited for: VARIANT NASKAPI/MERSIN GLU-396; VARIANT MEXICO GLY-574;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.